MAPT and Alzheimer disease: In more detail, zinc sulfate administration is able to restore normal levels of tau, APP, and α-synuclein and to ameliorate the histological architecture altered by Al in mice; furthermore, Zn counteracts the toxic effects of Cu (which fuels ROS formation) at the brain level, limiting its intestinal absorption in AD patients [558,559,560,593].